Molnupiravir excluded from revised clinical guidelines for management of adult COVID-19 patients

central government Not included The antiviral drug mollupiravir in its Revised Clinical Guidance for the Management…

A cognitive dissonance in drug regulation?

The letter raised several issues, including the fact that India was promoting expensive diagnostics and drugs…

Coronavirus Live Updates | Kovid negative report necessary in Ganga Sagar fair: Calcutta HC

India’s COVID-19 vaccination coverage crossed 153.7 crore on Tuesday, with 76,68,282 vaccine doses given till 7…

Molnupiravir still out of COVID-19 clinical management protocol

New Delhi : The ICMR’s National Task Force for COVID-19 has so far decided against the…

Coronavirus treatment: do you need molanupiravir, monoclonal antibody cocktail or symptom-based treatment only if you test COVID positive? Here’s a lecturer – Times of India

We have been living with COVID for over two years now but it feels like forever.…

Will India benefit from two new COVID treatments?

As Indian hospitals prepare for a potential increase in admissions of Covid-19 patients, two new antiviral…

Kovid Antiviral Pill India: Kovid Antiviral Pill launched at Rs 1,399 for a full 5-day course. India News – Times of India

Mumbai: molanupiravirAntiviral drug that recently got emergency use approval for the treatment of mild to moderate…

COVID: Launched: India’s 1st COVID Antiviral Pill at Rs 1,399 | News – Times of India Videos

Jan 04, 2022, 03:57 PM ISTSource: TOI.in Mankind Pharma’s COVID antiviral drug, Molnupiravir, has been launched…

New COVID-19 pills carry risks: What patients need to know

In December, the Food and Drug Administration, along with Merck & Co., its partners Ridgeback Biotherapeutics,…

Maximizing the Boost: On Combining COVID-19 Vaccines

India must test viability of vaccine mix to help enable informed choice Initiating a new frontier…